ZJY-54
ZJY-54 is an orally active dual-target inhibitor of EGFR/LSD1, with IC50 values of 3.8 nM and 0.6 μM, respectively. ZJY-54 can inhibit the proliferation of non-small cell lung cancer cells, induce the accumulation of H3K4me2 and H3K9me2, and inhibit the phosphorylation of the EGFR signaling pathway. ZJY-54 has anti-tumor activity[1].
Product Specifications
UNSPSC
12352211
Target
EGFR; Histone Demethylase
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
COC1=C(C=C(C(N2C[C@@H](CC2)N(C)C)=C1)NC(C=C)=O)NC3=NC(C4=CN(C([2H])([2H])[2H])C5=CC=CC=C54)=CC=N3
Molecular Formula
C29H30D3N7O2
Molecular Weight
514.64
References & Citations
[1]Zhang J, et al. Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers. J Med Chem. 2025 Mar 13;68 (5) :5954-5972.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
SC400608 10 µg
MIR631 Human MicroRNA Expression Plasmid (MI0003645)
Sign In for Pricing
View Details 
GTR10327115 96 Well
Porcine ADP/ATP translocase 4 (SLC25A31) ELISA Kit
Sign In for Pricing
View Details 
LC421084 20 µg
CR16 (WIPF3) (NM_001080529) Human Over-expression Lysate
Sign In for Pricing
View Details